Netanya, Israel

Jenny Goldshtein

This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Assia Chemical Industries Ltd.. Active years: 2022-2026.

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.3

ph-index = 1


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Jenny Goldshtein

Introduction: Jenny Goldshtein is a prominent inventor based in Netaniya, Israel, known for her significant contributions to the field of pharmaceuticals. With one patent to her name, she has made noteworthy advancements that aim to improve therapeutic options for various health conditions.

Latest Patents: Goldshtein's most recognized patent revolves around "Crystalline polymorphs of Pracinostat and Pracinostat salts." This patent encompasses innovative crystalline forms of Pracinostat and its salts, as well as the pharmaceutical compositions derived from these polymorphs. The work signifies a critical step in enhancing the efficacy and stability of this compound for medicinal use.

Career Highlights: Throughout her career, Jenny Goldshtein has demonstrated a commitment to scientific excellence and innovation. Her role at Assia Chemical Industries Ltd. has allowed her to collaborate with some of the best minds in the industry, ultimately leading to her significant patent achievement.

Collaborations: At Assia Chemical Industries Ltd., Goldshtein has worked alongside talented colleagues, including Maytal Piran and Doron Rudik. Their collaborative efforts have been instrumental in developing and refining the research that led to Goldshtein's groundbreaking patent.

Conclusion: Jenny Goldshtein embodies the spirit of innovation and dedication within the pharmaceutical industry. Her patent for crystalline polymorphs of Pracinostat marks a noteworthy advancement, promising improved treatment avenues in healthcare. With ongoing research and collaboration with esteemed colleagues, her impact on the field is likely to grow even further.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…